Copyright
©The Author(s) 2024.
World J Diabetes. Feb 15, 2024; 15(2): 287-304
Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.287
Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.287
Figure 6 Duodenal jejunal bypass surgery improves diabetes-induced hypothalamic cell apoptosis in type 2 diabetes mellitus rats.
A: The quantitative real-time (qRT)-PCR results of Caspase-3 expression; B: The qRT-PCR results of Bcl-2 expression; C: Expression levels of apoptosis-related proteins in the hypothalamus by Western blotting; D: The quantitative densitometric analysis of apoptosis-related proteins. aP < 0.05, bP < 0.01, cP < 0.001. T2DM: Type 2 diabetes mellitus; DJB: Duodenal jejunal bypass.
- Citation: Wang HJ, Zhang LB, Sun SP, Yan QT, Gao ZQ, Fu FM, Qu MH. Duodenal-jejunal bypass improves hypothalamic oxidative stress and inflammation in diabetic rats via glucagon-like peptide 1-mediated Nrf2/HO-1 signaling. World J Diabetes 2024; 15(2): 287-304
- URL: https://www.wjgnet.com/1948-9358/full/v15/i2/287.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i2.287